Citius Oncology (CTOR) EBIT (2023 - 2026)
Citius Oncology (CTOR) posted quarterly EBIT of -$28.6 million for Q1 2026, down 282.98% year-over-year from $15.6 million in Q1 2025, and down 444.78% quarter-over-quarter from -$5.3 million in Q4 2025.
Citius Oncology (CTOR) EBIT (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported EBIT for 4 consecutive years, with -$28.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT fell 282.98% year-over-year to -$28.6 million; the TTM figure through Mar 2026 stood at -$43.5 million (down 55.22% YoY), while the FY2025 annual figure was -$23.5 million, down 14.34% from the prior year.
- EBIT fell to -$28.6 million in Q1 2026 per CTOR's latest filing, from -$5.3 million in the prior quarter.
- Across five years, EBIT topped out at -$147922.0 in Q1 2023 and bottomed at -$28.6 million in Q1 2026.
- Historically, EBIT has averaged -$6.4 million across 4 years, with a median of -$4.8 million in 2025.
- Annual changes were most pronounced in 2024 — EBIT slumped 6867.44% — and 2025, when it soared 64.43%.
- Citius Oncology's EBIT stood at -$4.6 million in 2023, then tumbled by 40.45% to -$6.4 million in 2024, then gained by 17.87% to -$5.3 million in 2025, then slumped by 444.78% to -$28.6 million in 2026.
- Business Quant data shows CTOR's EBIT at -$28.6 million in Q1 2026, -$5.3 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Citius Oncology | 79.84 Mn | 79.84 Mn | 1.00 Mn | -8.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.61 Mn |
| Dec 31, 2025 | -5.25 Mn |
| Sep 30, 2025 | -4.71 Mn |
| Jun 30, 2025 | -4.94 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -6.39 Mn |
| Jun 30, 2024 | -13.90 Mn |
| Mar 31, 2024 | -268,429.00 |
| Dec 31, 2023 | -4.55 Mn |
| Sep 30, 2023 | -768,931.00 |
| Jun 30, 2023 | -199,554.00 |
| Mar 31, 2023 | -147,922.00 |